World's Best Scientists 2026 revealed!
Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
112
Citations
55597
World Ranking
5091
National Ranking
157

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Franco Mandelli was affiliated with Sapienza University of Rome in Italy and contributed to medical research with a focus on hematology and public health. Their work notably intersected with the study of leukemia, addressing various aspects of chronic and acute forms of this disease.

Their research output included studies published in venues such as PubMed. One of their recent papers, published in 2022, explored the use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as a post-transplant therapy for chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.

Frequent topics covered in their work were:

  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research

The main fields of study associated with their publications included:

  • Medicine

Within medicine, they focused on the following subfields:

  • Hematology
  • Public Health, Environmental and Occupational Health

Frequent co-authors that collaborated with them on research projects included Carmelo Carlo-Stella, E. Regazzi, Cristina Andrizzi, Barbara Savoldo, and D. Garau.

Their contribution to scientific literature is recorded primarily through peer-reviewed articles relevant to hematological malignancies and treatment methodologies.

Best Publications

  • Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

    T Philip;C Guglielmi;A Hagenbeek;R Somers

  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

    Hagop M Kantarjian;Charles Sawyers;Andreas Hochhaus;Francois Guilhot

  • Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

    Brunangelo Falini;Christina Mecucci;Enrico Tiacci;Myriam Alcalay

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

    R. A. Zittoun;F. Mandelli;R. Willemze;T. De Witte

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

    Paolo Rebulla;Guido Finazzi;Francesca Marangoni;Giuseppe Avvisati

  • Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

    Franco Mandelli;Daniela Diverio;Giuseppe Avvisati;Anna Luciano

  • Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review.

    Alessandro Pulsoni;Gabriel Anghel;Paolo Falcucci;Roberta Matera

  • Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival

    Sabina Chiaretti;Xiaochun Li;Xiaochun Li;Robert Gentleman;Robert Gentleman;Antonella Vitale;Antonella Vitale

  • Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Robin Foà;Antonella Vitale;Marco Vignetti;Giovanna Meloni

  • Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

    Stefan Suciu;Franco Mandelli;Theo de Witte;Robert Zittoun

  • Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

    Marco Vignetti;Paola Fazi;Giuseppe Cimino;Giovanni Martinelli

  • Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

    Luciana Annino;Maria Luce Vegna;Andrea Camera;Giorgina Specchia

  • Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

    Uwe Platzbecker;Giuseppe Avvisati;Laura Cicconi;Christian Thiede

  • Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

    Mandelli F;Avvisati G;Amadori S;Boccadoro M

  • A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

    Hervé Dombret;Claude Chastang;Pierre Fenaux;Josy Reiffers

  • Early Detection of Relapse by Prospective Reverse Transcriptase-Polymerase Chain Reaction Analysis of the PML/RARα Fusion Gene in Patients With Acute Promyelocytic Leukemia Enrolled in the GIMEMA-AIEOP Multicenter “AIDA” Trial

    D Diverio;V Rossi;G Avvisati;S De Santis

  • Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Francesco Lo-Coco;Giuseppe Avvisati;Marco Vignetti;Massimo Breccia

Frequent Co-Authors

Sergio Amadori
Sergio Amadori University of Rome Tor Vergata
Robin Foà
Robin Foà Sapienza University of Rome
Giorgina Specchia
Giorgina Specchia University of Bari Aldo Moro
Maria Teresa Petrucci
Maria Teresa Petrucci Sapienza University of Rome
Michele Baccarani
Michele Baccarani University of Bologna
Giuseppe Leone
Giuseppe Leone Catholic University of the Sacred Heart
Francesco Di Raimondo
Francesco Di Raimondo University of Catania
William Arcese
William Arcese Sapienza University of Rome
Francesco Lo-Coco
Francesco Lo-Coco University of Rome Tor Vergata
Sante Tura
Sante Tura University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up many related fields with online degree options. For aspiring psychiatric nurse practitioners, you may want to explore the fastest post master's pmhnp programs to quickly advance your qualifications and clinical skills.

If you’re interested in the business side of healthcare, an online healthcare administration degree can provide a flexible entry into management roles. For those seeking value, finding the cheapest online healthcare administration degree is an excellent way to reduce education costs without sacrificing quality.

At the graduate level, pursuing a Master’s in Healthcare Administration is a popular choice. Understanding the mha degree cost can help you budget for your education and compare programs before you enroll.

For those aiming for leadership or advanced clinical roles, the Doctor of Nursing Practice is increasingly in demand. Many flexible and cheap online dnp programs are now available to help experienced nurses reach the highest level of practice affordably.

Best Scientists Citing Franco Mandelli